SOLVO Biotechnology introduces Predicell™ for OATP1B3, OATP1B1 and OCT2
March 11, 2011
SOLVO proudly introduces PREDICELLTM, the world’s first commercially available ready-to-use uptake transporter assay kits for OATP1B3, OATP1B1 and OCT2.- Perform uptake transporter studies in-house
- Run uptake assays without cell culturing
- Access to uptake transporters without cell line development or licensing The assays are available
- 96-well kit for inhibition studies
- 24-well kit for direct uptake studies (substrate assessment)
Next entry: The Revolutionary Ready-to-use Transfected MDCKII Monolayer System is Now Available for BCRP
Previous entry: SOLVO Hosts DMDG Spring Meeting in Budapest between 24-25 March 2011
